Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into higher Cardiorenal Outcomes.

Jaejin An,Hui Zhou,Liang Ni,Teresa N Harrision,Rong Wei,Abiy Agiro,Yasmin Ghanshyam Brahmbhatt,Yemmie Oluwatosin,Craig Schilling,John J Sim

American journal of nephrology（2023）

引用 0|浏览11

暂无评分

摘要

RAASi discontinuation after hyperkalemia was associated with worsened mortality, which may underscore the benefits of continuing RAASi among patients with CKD.

查看译文

关键词

Hyperkalemia, Renin-angiotensin-aldosterone system inhibition, Medication use, Kidney outcome, Mortality

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要